Alex Asiimwe
About
Alex Asiimwe is a scholar working on Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Alex Asiimwe has authored 27 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alex Asiimwe's work include Reproductive Health and Contraception (7 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Alex Asiimwe is often cited by papers focused on Reproductive Health and Contraception (7 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Alex Asiimwe collaborates with scholars based in Germany, United Kingdom and United States. Alex Asiimwe's co-authors include Pareen Vora, David Ofori‐Adjei, Edmund T. Nartey, Carole Fogg, Michael R. Thompson, Esther Artime, Montse Soriano‐Gabarró, Nawab Qizilbash, Sally Kilburn and David Prytherch and has published in prestigious journals such as Annals of Oncology, British journal of surgery and BMJ Open.
In The Last Decade
Alex Asiimwe
26 papers receiving 346 citations
Peers
Alex Asiimwe
B. Gourieux France
Ana Paula Martins Portugal
Anand Harugeri India
Hassan Torkamandi Iran
Francesco Innocenti Italy
Susan Andrade United States
Sudip Shrestha Nepal
Tiffany S. Woodworth United States
Khokan C. Sikdar Canada
Aarthi Iyer United States
Citations per year, relative to Alex Asiimwe Alex Asiimwe (= 1×)
peers
B. Gourieux
Countries citing papers authored by Alex Asiimwe
Since
Specialization
Citations
This map shows the geographic impact of Alex Asiimwe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Asiimwe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Asiimwe more than expected).
Fields of papers citing papers by Alex Asiimwe
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Alex Asiimwe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Asiimwe. The network helps show where Alex Asiimwe may publish in the future.
Co-authorship network of co-authors of Alex Asiimwe
This figure shows the co-authorship network connecting the top 25 collaborators of Alex Asiimwe. A scholar is included among the top collaborators of Alex Asiimwe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Asiimwe. Alex Asiimwe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Vora, Pareen, Henry Morgan Stewart, Beth Russell, Alex Asiimwe, & Gunnar Brobert. (2022). Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States. International Journal of Clinical Practice. 2022(1). 6707985–6707985.
2.
N’Dow, James, Emma Jane Smith, Monique J. Roobol, et al.. (2022). 917P OPTIMA: Improve care for patients with prostate, breast, and lung cancer through artificial intelligence. Annals of Oncology. 33. S966–S966.
3.
Yu, Thomas, et al.. (2022). Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases. BMC Medical Informatics and Decision Making. 22(1). 31–31.
4.
Beyer, Katharina, Lisa Moris, Michael Lardas, et al.. (2021). Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol. BMJ Open. 11(2). e040531–e040531.
5.
Kikaire, Bernard, et al.. (2021). HIV viral load suppression following intensive adherence counseling among people living with HIV on treatment at military-managed health facilities in Uganda. International Journal of Infectious Diseases. 112. 45–51.
6.
Raine‐Bennett, Tina, Michael J. Fassett, Malini Chandra, et al.. (2021). Ectopic pregnancy prevention: Further evidence of benefits of prescription contraceptives. Contraception. 105. 19–25.
7.
Sauer, Ursula G., Alex Asiimwe, Philip A. Botham, et al.. (2020). Toward a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny – part I: which parameters from human studies are most relevant for toxicological assessments?. Critical Reviews in Toxicology. 50(9). 740–763.
8.
Beest, Fernie J. A. Penning‐van, Irene D. Bezemer, Luis A. Garcı́a Rodrı́guez, et al.. (2020). Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy. Contraception. 102(4). 243–245.
9.
Getahun, Darios, Jiaxiao Shi, Malini Chandra, et al.. (2020). Identifying Ectopic Pregnancy in a Large Integrated Health Care Delivery System: Algorithm Validation. JMIR Medical Informatics. 8(11). e18559–e18559.
10.
Soriano, Lucía Cea, Alex Asiimwe, Mieke Van Hemelrijck, Cecilia Bosco, & Luis A. Garcı́a Rodrı́guez. (2020). Feasibility study to identify women of childbearing age at risk of pregnancy not using any contraception in The Health Improvement Network (THIN) database. BMC Medical Informatics and Decision Making. 20(1). 164–164.
11.
Vora, Pareen, et al.. (2018). A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post‐Authorization Studies. Pharmacoepidemiology and Drug Safety. 27(7). 695–706.
12.
Davis, Kimberly H., Alex Asiimwe, L. Zografos, David McSorley, & Elizabeth Andrews. (2017). Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey. Pharmaceutical Medicine. 31(5). 339–351.
13.
Soriano, Lucía Cea, Alex Asiimwe, & Luis A. Garcı́a Rodrı́guez. (2016). Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network. Contraception. 95(3). 299–305.
14.
Hallgreen, Christine E., Shahrul Mt‐Isa, A Lieftucht, et al.. (2015). Literature review of visual representation of the results of benefit–risk assessments of medicinal products. Pharmacoepidemiology and Drug Safety. 25(3). 238–250.
15.
Asiimwe, Alex, Andrew Bate, Fatima Bhayat, et al.. (2014). Structured Assessment for Prospective Identification of Safety Signals in Electronic Medical Records: Evaluation in the Health Improvement Network. Drug Safety. 38(1). 87–100.
16.
Asiimwe, Alex, et al.. (2013). Diagnoses of Gastrointestinal Cancers After Gastrointestinal Bleeding in Patients Receiving Clopidogrel or Warfarin. Current Drug Safety. 8(4). 261–269.
17.
Asiimwe, Alex, Fraser Brims, Neil P. Andrews, et al.. (2011). Routine Laboratory Tests can Predict In-hospital Mortality in Acute Exacerbations of COPD. Lung. 189(3). 225–232.
18.
Brims, Fraser, Alex Asiimwe, David Prytherch, et al.. (2011). Weekend admission and mortality from acute exacerbations of chronic obstructive pulmonary disease in winter. Clinical Medicine. 11(4). 334–339.
19.
Thompson, Michael R., et al.. (2010). Is earlier referral and investigation of bowel cancer patients presenting with rectal bleeding associated with better survival?. Colorectal Disease. 13(11). 1242–1248.
20.
Fogg, Carole, et al.. (2009). Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy. Malaria Journal. 8(1). 2–2.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by B. Gourieux Breakdown of academic impact, for papers by Ana Paula Martins Breakdown of academic impact, for papers by Anand Harugeri Breakdown of academic impact, for papers by Hassan Torkamandi Breakdown of academic impact, for papers by Francesco Innocenti Breakdown of academic impact, for papers by Susan Andrade Breakdown of academic impact, for papers by Sudip Shrestha Breakdown of academic impact, for papers by Tiffany S. Woodworth Breakdown of academic impact, for papers by Khokan C. Sikdar Breakdown of academic impact, for papers by Aarthi Iyer